Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine efficacy and safety of the biweekly scheme with
Capecitabine and Irinotecan, plus bevacizumab in patients with metastatic colorectal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)